NCT02902822

Brief Summary

The purpose of this study is to demonstrate the validity and utility of a tele-dermatology system in the midterm periodic screening of non-widespread skin lesions of recent onset or for which a specialized early classification is deemed to change the prognosis - including precancerous skin lesions as well as melanoma and non-melanoma skin cancers - compared to control visits at fixed follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
461

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 16, 2016

Completed
15 days until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

May 17, 2019

Status Verified

May 1, 2019

Enrollment Period

2.6 years

First QC Date

September 8, 2016

Last Update Submit

May 16, 2019

Conditions

Keywords

melanomanon-melanoma skin cancermoleappcliccailneo

Outcome Measures

Primary Outcomes (1)

  • Cumulative incidence of at least one non-widespread skin lesion identified and clinically confirmed as suspected / highly suspected

    Two years

Secondary Outcomes (4)

  • Agreement between the tele-dermatology system and the direct dermatological visit as assessed by Cohen's kappa (within the experimental arm).

    Within the two years study period

  • Cumulative incidence of at least one non-widespread skin lesion identified as suspected / highly suspected among subjects who did not use the tele-dermatology system (within the experimental arm).

    Within the two years study period

  • Proportion of subjects who have at least one anticipated follow-up visit (within the comparator arm).

    Within the two years study period

  • Proportion of subjects with at least one missed scheduled visit at follow-up(within the comparator arm).

    Within the two years study period

Study Arms (2)

Screening

ACTIVE COMPARATOR

This arm includes all subjects randomized to regular dermatological follow-up visits on annual basis.

Procedure: Screening

Tele-dermatology

EXPERIMENTAL

This arm includes all subjects randomized to the use of a tele-dermatology system for the evaluation of newly onset non-widespread skin lesions.

Device: Tele-dermatology

Interventions

ScreeningPROCEDURE

The screening visit consists in a general dermatological examination of the subject, with special focus on the onset of the following skin diseases during the follow-up period: 1. bacterial skin infections - pyoderma - or viral (erysipelas, impetigo, herpes zoster, molluscum contagiosum, viral warts); 2. fungal skin infections (tinea corporis, cruris, pedis); 3. pigmented tumors (melanoma); 4. non-melanocytic tumors (actinic keratoses, basal cell or squamous cell carcinoma).

Screening

The system consists in a simple web-based/smartphone application through which subjects can send pictures of recently onset non-widespread skin lesions with special focus on the following diseases: 1. bacterial skin infections - pyoderma - or viral (erysipelas, impetigo, herpes zoster, molluscum contagiosum, viral warts); 2. fungal skin infections (tinea corporis, cruris, pedis); 3. pigmented tumors (melanoma); 4. non-melanocytic tumors (actinic keratoses, basal cell or squamous cell carcinoma). A dermatology will judge online pictures based on a standard scale. Each subject who will use the system will be also seen by routine clinical visit to confirm the online diagnosis. Subjects who will not send any picture will be seen for a dermatological examination at the end of each year.

Tele-dermatology

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects currently working at the Local Health Authority of the province of Bergamo

You may not qualify if:

  • Subjects who are not able to use the tele-dermatology system or who have no access to the website or the specific app.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Local Health Authority (ATS)

Bergamo, 24121, Italy

Location

MeSH Terms

Conditions

ErysipelasImpetigoHerpes ZosterMolluscum ContagiosumWartsTineaMelanomaKeratosis, ActinicCarcinoma, Basal CellCarcinoma, Squamous CellNevusAlzheimer Disease

Interventions

Mass Screening

Condition Hierarchy (Ancestors)

Streptococcal InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsSkin Diseases, BacterialSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue DiseasesStaphylococcal Skin InfectionsStaphylococcal InfectionsVaricella Zoster Virus InfectionHerpesviridae InfectionsDNA Virus InfectionsVirus DiseasesPoxviridae InfectionsSkin Diseases, ViralPapillomavirus InfectionsTumor Virus InfectionsDermatomycosesMycosesNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve TissueNevi and MelanomasSkin NeoplasmsNeoplasms by SitePrecancerous ConditionsKeratosisCarcinomaNeoplasms, Glandular and EpithelialNeoplasms, Basal CellNeoplasms, Squamous CellDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Practice

Study Officials

  • Luigi Naldi, MD

    Centro Studi Gised

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2016

First Posted

September 16, 2016

Study Start

October 1, 2016

Primary Completion

May 1, 2019

Study Completion

May 1, 2019

Last Updated

May 17, 2019

Record last verified: 2019-05

Locations